Overview

The Personalized Chinese Herb Formulas Over Hypertensive Bradyarrhythmia

Status:
Completed
Trial end date:
2020-06-20
Target enrollment:
Participant gender:
Summary
72 patients who have been diagnosed with hypertensive bradyarrhythmia were selected and randomly divided into research group and control group. The research group received regular medication against hypertension and the personalized formulas based on syndrome differentiation, meanwhile the control group only received the regular medication. The five symptoms (palpitation, short of breath, angina, dizzy and lumbar debility) were graded and used for evaluation of treatment.
Phase:
N/A
Details
Lead Sponsor:
Jun Xiao
Collaborator:
Qingdao Fifth People's Hospital
Treatments:
Atropine